About Neuropacs
Neuropacs is a healthcare AI company that develops an AI-based imaging software suite designed to detect, analyze, and measure changes associated with neurodegenerative diseases. Their platform offers imaging analysis tools and proprietary algorithms that are compatible with existing imaging workflows. This technology enables clinicians and clinical researchers to support diagnosis and evaluate disease progression in both research and clinical settings.
Specifically for physicians, Neuropacs provides automated MRI processing and machine learning software to assist in diagnosing and differentiating common neurodegenerative forms of parkinsonism, including Parkinson’s disease (PD), multiple system atrophy parkinsonian variant (MSA), and progressive supranuclear palsy (PSP). The software utilizes a free-water imaging model to assess for neurodegeneration and a machine learning algorithm to analyze brain scans, providing clinicians with results indicating the likely presence of PD, MSA, or PSP. The test relies on a single, non-invasive diffusion MRI scan without radiotracers, and can be performed on 3 Tesla scanners from major vendors (Siemens, GE Healthcare, and Philips). The FDA has granted De Novo classification to Neuropacs, establishing a new regulatory category for a “Parkinsonian syndrome diagnostic aid,” making it the first device cleared under this classification. This software is intended to provide supplemental information for neuroradiologists and neurologists as part of a broader clinical assessment, particularly when differentiating these conditions from Parkinson’s disease is challenging.
Focus Areas
Business Intelligence
| Technology | Cloud-based analysis platform, free-water imaging model, machine learning algorithm, compatible with standard diffusion MRI sequences on 3T MRI systems |
What Physicians Need to Know
Neuropacs offers physicians a crucial tool for more accurate and earlier differentiation of Parkinson's disease from atypical parkinsonism (MSAp and PSP), which are often challenging to distinguish clinically, especially in early stages. This can lead to more informed treatment planning and potentially revolutionize the standard of care for diagnosing parkinsonism. The system provides objective, imaging-derived information as a supplemental aid, and results should always be interpreted in conjunction with a comprehensive clinical evaluation and other diagnostic testing. The non-invasive nature of the diffusion MRI scan and its compatibility with standard 3T MRI systems from major vendors (Siemens, GE Healthcare, Philips) ensures ease of integration into existing workflows.
The Neuropacs software is designed for cloud-based analysis and integrates with existing MRI workflows, operating with standard diffusion MRI sequences on 3 Tesla clinical MRI systems from Siemens, GE Healthcare, and Philips. It is powered by AWS, ensuring scalability and high availability.
Reviews & Opinions
Videos
News, demos, and interviews about Neuropacs.
Videos load interactively. If none appear, search YouTube for Neuropacs →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded Neuropacs.
Related Companies
Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]
Veeva Systems is a global leader in cloud-based software solutions specifically designed for the life sciences industry, including pharmaceutical and biotech companies. The company’s offerings are crucial for managing various aspects of drug development, pharmaceutical manufacturing, and commercial operations. Their platforms help clients navigate complex regulatory requirements, improve operational efficiency, and accelerate the delivery of […]
The University at Buffalo (UB) is a prominent public research university and a flagship institution of the State University of New York (SUNY) system. While UB itself is a broad academic institution, the provided URL (halsted.compbio.buffalo.edu) points to a specific area within UB focused on computational biology. This division is actively engaged in healthcare AI […]
SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]
Prenaital is an AI-driven healthcare company focused on revolutionizing maternal care by improving the early detection and management of high-risk pregnancies. Their AI models analyze ultrasound images to identify at-risk pregnancies, including those with abnormal fetal growth and a risk of preterm birth, with significantly higher accuracy than current clinical practices—detecting 25-50% more high-risk cases. […]
PHQ Screeners is a free, open-access resource maintained by Pfizer, providing a comprehensive suite of Patient Health Questionnaire (PHQ) and Generalized Anxiety Disorder (GAD-7) screening instruments. These tools were developed by Drs. Robert L. Spitzer, Janet B.W. Williams, and Kurt Kroenke with an educational grant from Pfizer, and are widely utilized in primary care and […]